182 related articles for article (PubMed ID: 15602859)
21. Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
Isoda A; Nakahashi H; Hoshino T; Mitsui T; Yoshida Y
Am J Hematol; 2007 Jun; 82(6):501-2. PubMed ID: 17301971
[No Abstract] [Full Text] [Related]
22. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
23. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
Matolcsy A
Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
[TBL] [Abstract][Full Text] [Related]
24. [RT-PCR use for the diagnostic of chronic myeloid leukaemia].
Menif S; El Borgi W; Jeddi R; Belakhal R; Elloumi M; Laatiri A; Meddeb B; Dellagi K
Arch Inst Pasteur Tunis; 2006; 83(1-4):35-9. PubMed ID: 19388595
[TBL] [Abstract][Full Text] [Related]
25. NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid leukemia.
Grand FH; Koduru P; Cross NC; Allen SL
Leuk Res; 2005 Dec; 29(12):1469-72. PubMed ID: 15982735
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib.
Marin D; Kaeda JS; Andreasson C; Saunders SM; Bua M; Olavarria E; Goldman JM; Apperley JF
Cancer; 2005 May; 103(9):1850-5. PubMed ID: 15786422
[TBL] [Abstract][Full Text] [Related]
27. Translocation (9;22;21) in a chronic myeloid leukemia fluorescence in situ hybridization definition.
Vallcorba I; García-Sagredo JM; San Román C; Ferro MT; González A; Cabello P; Villegas A
Cancer Genet Cytogenet; 1998 Jul; 104(1):72-3. PubMed ID: 9648564
[No Abstract] [Full Text] [Related]
28. Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia.
Mattarucchi E; Guerini V; Rambaldi A; Campiotti L; Venco A; Pasquali F; Lo Curto F; Porta G
Genes Chromosomes Cancer; 2008 Jul; 47(7):625-32. PubMed ID: 18398823
[TBL] [Abstract][Full Text] [Related]
29. Constitutional Robertsonian translocations in (9;22)-positive chronic myelogenous leukemia.
Qian J; Xue Y; Sun J; Guo Y; Pan J; Wu Y; Wang W; Yao L
Cancer Genet Cytogenet; 2002 Jan; 132(1):79-80. PubMed ID: 11801317
[No Abstract] [Full Text] [Related]
30. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous occurrence of t(9;22)(q34;q11.2) and t(16;16)(p13;q22) in a patient with chronic myeloid leukemia in blastic phase.
Zámecníkova A; Al Bahar S; Ramesh P
Cancer Genet Cytogenet; 2008 Jun; 183(2):109-13. PubMed ID: 18503829
[TBL] [Abstract][Full Text] [Related]
32. Concomitant translocation t(14;22)(q32;q11) in a case of chronic myeloid leukemia.
Orciuolo E; Buda G; Galimberti S; Cecconi N; Cervetti G; Petrini M
Leuk Res; 2008 Jan; 32(1):188-90. PubMed ID: 17346791
[No Abstract] [Full Text] [Related]
33. Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
Medeiros BC; Markovic V; Kamel-Reid S; Lipton JH
Cancer Genet Cytogenet; 2007 Feb; 173(1):83-4. PubMed ID: 17284377
[No Abstract] [Full Text] [Related]
34. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
[No Abstract] [Full Text] [Related]
35. Complex translocation t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index in chronic myeloid leukaemia.
Orciuolo E; Buda G; Galimberti S; Cervetti G; Cecconi N; Papineschi F; Petrini M
Leuk Res; 2008 Jan; 32(1):190-1. PubMed ID: 17418404
[No Abstract] [Full Text] [Related]
36. Two siblings with chronic myelogenous leukemia.
Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
[TBL] [Abstract][Full Text] [Related]
37. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
38. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
39. Additional rearrangements affecting the derivative chromosome 9 involved in the standard Philadelphia translocation after imatinib therapy in a patient with chronic myeloid leukemia.
Wang HP; Chen ZM; Lou JY; Xu H; Yu YB; Jin J
Cancer Genet Cytogenet; 2008 Apr; 182(1):63-4. PubMed ID: 18328955
[No Abstract] [Full Text] [Related]
40. Isolated myelosarcoma development in an adolescent chronic myeloid leukemia patient with t(9;22)(q34;q11.2), +8, +14, +21, and der(1)(p36).
Oren H; Yilmaz S; Sercan Z; Demircioğlu F; Yüksel E; Irken G
Cancer Genet Cytogenet; 2008 Apr; 182(1):43-5. PubMed ID: 18328950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
